Cover image of the article: Flowcytometric assessment of monocyte-derived dendritic cell efficiency for tumor cell lysate uptake in chronic lymphocytic leukemia patients

Image Credit:Koomesh

Flowcytometric assessment of monocyte-derived dendritic cell efficiency for tumor cell lysate uptake in chronic lymphocytic leukemia patients

Authors

Parviz Kokhaei,*, Reza Mahdian, Fateme Pak, Shirin Shahbazi, Bizhan SedighiMoghadam
*Corresponding Author: Email: parviz_kokhaei@cck.ki.se

Koomesh:Vol. 4, issue 1; 29-38
Published online:Aug 30, 2002
Article type:Research Article
How to Cite:Kokhaei P, Mahdian R, Pak F, Shahbazi S, SedighiMoghadam B. Flowcytometric assessment of monocyte-derived dendritic cell efficiency for tumor cell lysate uptake in chronic lymphocytic leukemia patients. koomesh. 2002;4(1):e151962. doi:

Abstract

Introduction: Dendritic cells (DCs) are the most potent antigen presenting cells in the immune system. They are strongly involved in init iation of primary immune response , autoimmune disease, graft rejection, HIV infection and antitumor response. However, the capability of DCs to activate tumor specific r cells in chronic lymphocytic leukemia (CLL) has been reported, direct demonstration of soluble antigens of tumor lysate uptake had not been shown. In this study we have shown uptake of antigen molecules by immature DCs using Flow cytometric techniques. Material and Methods: DCs of two CLL patients and two healthy donors have been evaluated in this study. Peripheral blood monocytes have been purified using mouse anti-CDl4 coated magnetic beads and then' undergone culture process in the presence of rhGM-CSF and rhILA. Generated DCs have been assessed for their ability of uptake FITC-labeled proteins of tumoural B cells lysate by tlow cytometry. Results: Fluorescence intensity in DCs pulsed with FITC-labeled tumor lysat e , after using surface tluorescence quencher (trypan blue), were clearly more than unpulsed controls. This was true for both CLL patients DCs and healthy donors DCs . Conclusion: Immature DCs are capable to uptake soluble protein molecules of tumor lysate prepared from B cells of CLL patients.

Highlights

Copyright

© 2002, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

2
Aug
2021
Effect of IL-27 on activity of bone marrow NK cells of patient with B-chronic lymphocytic leukemia in vitro

Effect of IL-27 on activity of bone marrow NK cells of patient with B-chronic lymphocytic leukemia in vitro

Abdolvahid Sadeghnejad,
Maral Hemati,
Mehrnoosh Pashaei,
Zahra Rasouli Nejad,
Farahnaz Ghahremanfard,
Parviz Kokhaei

Sadeghnejad A, Hemati M, Pashaei M, Rasouli Nejad Z, Ghahremanfard F, et al. Effect of IL-27 on activity of bone marrow NK cells of patient with B-chronic lymphocytic leukemia in vitro. koomesh. 2021;23(1):e153248. doi:

12
Aug
2025
Expression Modulation of Immune Inhibitory Molecules by Small Molecule Inhibitor Drugs in Leukemic Cells of Chronic Lymphocytic Leukemia

Expression Modulation of Immune Inhibitory Molecules by Small Molecule Inhibitor Drugs in Leukemic Cells of Chronic Lymphocytic Leukemia

Fatemeh Mousavi-Mirkalaei,
Saeid Taghiloo,
Maryam Alizadeh-Foroutan,
Ehsan Zaboli,
Mohammad Eslami-Jouybari,
Ramin Shekarriz
,et al.

Mousavi-Mirkalaei F, Taghiloo S, Alizadeh-Foroutan M, Zaboli E, Eslami-Jouybari M, et al. Expression Modulation of Immune Inhibitory Molecules by Small Molecule Inhibitor Drugs in Leukemic Cells of Chronic Lymphocytic Leukemia. Iran J Pharm Res. 2025;24(1):e159353. doi: https://doi.org/10.5812/ijpr-159353

28
Sep
2015
Therapeutic effects of fludarabine-cyclophosphamide combined therapy in Iranian patients with B-cell chronic lymphocytic leukemia

Therapeutic effects of fludarabine-cyclophosphamide combined therapy in Iranian patients with B-cell chronic lymphocytic leukemia

Kamran Moshfeghi,
Dr Ghasem Mosayebi

Moshfeghi K, Mosayebi DG. Therapeutic effects of fludarabine-cyclophosphamide combined therapy in Iranian patients with B-cell chronic lymphocytic leukemia. koomesh. 2015;16(2):e151299. doi:

21
May
2014
The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia

The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia

Fatemeh M. Kamazani,
Gholamreza Bahoush-Mehdiabadi,
Mahnaz Aghaeipour,
Shahram Vaeli,
Zahra Amirghofran

M. Kamazani F, Bahoush-Mehdiabadi G, Aghaeipour M, Vaeli S, Amirghofran Z. The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia. Inn J Pediatr. 2014;24(4):. doi:

5
Dec
2018
Flow Cytometry of CD64, HLA-DR, CD25, and TLRs for Diagnosis and Prognosis of Sepsis in Critically Ill Patients Admitted to the Intensive Care Unit: A Review Article

Flow Cytometry of CD64, HLA-DR, CD25, and TLRs for Diagnosis and Prognosis of Sepsis in Critically Ill Patients Admitted to the Intensive Care Unit: A Review Article

Ata Mahmoodpoor,
Seyedpouya Paknezhad,
Kamran Shadvar,
Hadi Hamishehkar,
Ali Akbar Movassaghpour,
Sarvin Sanaie
,et al.

Mahmoodpoor A, Paknezhad S, Shadvar K, Hamishehkar H, Movassaghpour AA, et al. Flow Cytometry of CD64, HLA-DR, CD25, and TLRs for Diagnosis and Prognosis of Sepsis in Critically Ill Patients Admitted to the Intensive Care Unit: A Review Article. Anesth Pain Med. 2018;8(6):e83128. doi: https://doi.org/10.5812/aapm.83128

More by these authors

Parviz KokhaeiPubMedScholar
Reza MahdianPubMedScholar
Fateme PakPubMedScholar
Shirin ShahbaziPubMedScholar
Bizhan SedighiMoghadamPubMedScholar
Share
Cited by
Metrics